Vladimir A. Beloglazov
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Research Interests
Vladimir A. Beloglazov has a total of 173 co-authors. Here are the top co-authors by number of shared publications:
- Igor A. Yatskov
S. Georgievsky Medical Institute, V. Vernadsky Crimean Federal University
50 shared publications - Elizaveta Sergeevna Ageeva
S. Georgievsky Medical Institute, V. Vernadsky Crimean Federal University
11 shared publications - Eugene D. Kumelskiy
V.I. Vernadsky Crimean Federal University
10 shared publications - Galina N. Andreeva
V.I. Vernadsky Crimean Federal University
8 shared publications L.M. DuBuske
8 shared publications- Leyla Shamilevna Dudchenko
Academic Research Institute of Physical Methods of Treatment, Medical Climatology and Rehabilitation named after I.M. Sechenov
8 shared publications
Latest Publications
- Open Access
- 12 October 2026
- Published by Northern State Medical University in The Russian Archives of Internal Medicine
- Vol. 16 (5) , 353-361
The Relationship of Markers of The Lipid Profile and Endotoxin-Binding Systems Under the Influence of Grape Polyphenols in Postcovid Patients with Bronchial Asthma During the Sanatorium Treatment
Relevance . Despite the high effectiveness of spa treatment in patients with bronchial asthma (BA), not all comorbid conditions can be eliminated by this treatment method, which necessitates the search for new methods of influencing various aspects of BA pathogenesis. Goal . To study the effect of grape polyphenols (GP) on the relationship between lipid profile parameters and markers of endotoxin-binding systems in post-COVID patients with BA during sanatorium treatment. Materials and methods . The study involved 105 BA patients treated at the Sechenov Sanatorium (Yalta). Group 1 (n=60) received GP, group 2 (n=45) did not. Body mass index (BMI), lipid profile, and markers of endotoxin-binding systems (BPI, LSB, LPS, sCD14, zonulin) were evaluated. Results . Significant changes in BPI, sCD14, and zonulin levels were observed in both groups during treatment. However, significant dynamics in BMI, HDL, LDL, and triglycerides were noted only in Group 1: BMI decreased from 29.4 kg/m² (23.5-33.9) to 29.0 kg/m² (23.2- 33.1) (p=0.04); HDL increased from 1.4 mmol/L (1.2-1.8) to 1.9 mmol/L (1.4-2.4) (p=0.01); LDL decreased from 3.5 mmol/L (2.7-4.3) to 3.0 mmol/L (2.5-3.4) (p=0.03); TG decreased from 1.1 mmol/L (0.9-1.6) to 0.9 mmol/L (0.7-0.9) (p=0.04). By the end of follow-up, intergroup comparison revealed significant differences in BMI (p=0.04), LDL (p=0.02), triglycerides (p=0.04), and LSB (p=0.03) levels. In Group 1, numerous correlations between lipid profile and endotoxin-binding system markers were identified before and after treatment. Conclusion . The prospects of using GP as an additional tool for correcting metabolic disorders in post-COVID patients with BA during sanatorium treatment have been confirmed.
- 12 October 2026
- Published by Northern State Medical University in The Russian Archives of Internal Medicine
- Vol. 16 (5) , 353-361
Open AccessThe Relationship of Markers of The Lipid Profile and Endotoxin-Binding Systems Under the Influence of Grape Polyphenols in Postcovid Patients with Bronchial Asthma During the Sanatorium Treatment
Relevance . Despite the high effectiveness of spa treatment in patients with bronchial asthma (BA), not all comorbid conditions can be eliminated by this treatment method, which necessitates the search for new methods of influencing various aspects of BA pathogenesis. Goal . To study the effect of grape polyphenols (GP) on the relationship between lipid profile parameters and markers of endotoxin-binding systems in post-COVID patients with BA during sanatorium treatment. Materials and methods . The study involved 105 BA patients treated at the Sechenov Sanatorium (Yalta). Group 1 (n=60) received GP, group 2 (n=45) did not. Body mass index (BMI), lipid profile, and markers of endotoxin-binding systems (BPI, LSB, LPS, sCD14, zonulin) were evaluated. Results . Significant changes in BPI, sCD14, and zonulin levels were observed in both groups during treatment. However, significant dynamics in BMI, HDL, LDL, and triglycerides were noted only in Group 1: BMI decreased from 29.4 kg/m² (23.5-33.9) to 29.0 kg/m² (23.2- 33.1) (p=0.04); HDL increased from 1.4 mmol/L (1.2-1.8) to 1.9 mmol/L (1.4-2.4) (p=0.01); LDL decreased from 3.5 mmol/L (2.7-4.3) to 3.0 mmol/L (2.5-3.4) (p=0.03); TG decreased from 1.1 mmol/L (0.9-1.6) to 0.9 mmol/L (0.7-0.9) (p=0.04). By the end of follow-up, intergroup comparison revealed significant differences in BMI (p=0.04), LDL (p=0.02), triglycerides (p=0.04), and LSB (p=0.03) levels. In Group 1, numerous correlations between lipid profile and endotoxin-binding system markers were identified before and after treatment. Conclusion . The prospects of using GP as an additional tool for correcting metabolic disorders in post-COVID patients with BA during sanatorium treatment have been confirmed.
- Open Access
- 13 August 2026
- Published by Northern State Medical University in The Russian Archives of Internal Medicine
- Vol. 16 (4) , 292-304
Assessment of The Effect of The A1166C Polymorphism of The AGTR1 Gene on The Formation of Comorbidity Associated with Cardiovascular Risk in patients with ankylosing spondylitis
Ankylosing spondylitis (AS) is a chronic inflammatory disease characterized by damage to the axial skeleton, peripheral joints and periarticular apparatus, manifestation of systemic manifestations with predominant involvement of the vascular membrane of the eye, skin with the development of psoriasis and intestines. AU is characterized by an earlier onset of arterial hypertension (AH), as well as a higher level of cardiovascular risk (CVR) associated with AH. Endothelial dysfunction as the initial stage of the development of cardiovascular diseases (CVD) can occur due to the activation of the prohormone renin and high activity of angiotensin (Ang) II. Ang II is involved not only in the regulation of blood pressure, but also performs hematopoietic functions, mainly erythropoiesis and myelopoiesis. Several studies have shown the association of AGTR1 (1166A>C) angiotensin II type 1 receptor polymorphism with hypertension, vasoconstriction, and sodium retention in the body. Therefore, it is potentially important to evaluate the role of oligonucleotide polymorphism (SNP) A1166C of the AGTR1 gene in the clinical manifestation of AS, as well as its significance in the development of comorbid pathology and the formation of CVR, including hypertension. Aim : to evaluate the effect of the A1166C polymorphism of the AGTR1 gene on the development of comorbid pathology and the formation of CFS, including AH. Materials and methods : The study included 176 patients diagnosed with AS. Genotyping was carried out according to the A1166C polymorphism of the AGTR1 gene by the polymerase chain reaction method (PCR). The statistical analysis was carried out using the Kruskal-Wallis criterion. Results: Patients with the AA genotype had a higher BASMI (Bath Ankylosing Spondylitis Metrology Index) (p=0024, p1,3=0.023). CC homozygotes had lower levels of red blood cells (p=0.025, p2,3=0.02) and hemoglobin (p=0.031, p2,3=0.042), while AA genotypes had lower platelet counts (p=0.0001, p1,3=0.001). Higher glucose levels were recorded in CC homozygotes (p=0,0001, p1,3=0,001, p1,2=0,025), triglycerides — in heterozygotes AC (p=0.038). The highest incidence of enthesitis was recorded for patients with the CC genotype (p2,3=0.006, p=0.015). High incidence of hypertension (p1,2=0.05, p=0.025), dyslipidemia (p1,2=0.012, p2,3=0.006, p=0.031) was found in heterozygotes of AC. Diabetes mellitus was detected only among patients with the CC genotype(p1,3=0.007, p=0.017). Kidney damage was more often detected in carriers of the A allele (p1,3=0.015, p2,3=0.004, p=0.023). Statistical differences were found in the frequency of detection of individual degrees of hypertension (p=0.0001): in heterozygotes of AC — 2 (AA 26 (27.1 %); AC 4 (33.3 %); CC 14 (24.1 %)) and grade 3 (AA 0 (0.0 %) versus AC 2 (16.7 %) CC 0 (0.0 %), p1,2C of the AGTR1 gene, extending beyond participation in the formation of hypertension, and include the regulation of hematopoiesis, metabolic parameters, glucose and lipids in particular, and the formation of comorbid pathology in the form of diabetes mellitus, dyslipidemia, kidney pathology in patients with AS, which determines the potential and feasibility of genotyping patients with AS with the identification of SNPs in order to personalize approaches to pharmacotherapy of AS and monitoring these indicators in the presence of a risk of developing conditions associated with this SNP.
- 13 August 2026
- Published by Northern State Medical University in The Russian Archives of Internal Medicine
- Vol. 16 (4) , 292-304
Open AccessAssessment of The Effect of The A1166C Polymorphism of The AGTR1 Gene on The Formation of Comorbidity Associated with Cardiovascular Risk in patients with ankylosing spondylitis
Ankylosing spondylitis (AS) is a chronic inflammatory disease characterized by damage to the axial skeleton, peripheral joints and periarticular apparatus, manifestation of systemic manifestations with predominant involvement of the vascular membrane of the eye, skin with the development of psoriasis and intestines. AU is characterized by an earlier onset of arterial hypertension (AH), as well as a higher level of cardiovascular risk (CVR) associated with AH. Endothelial dysfunction as the initial stage of the development of cardiovascular diseases (CVD) can occur due to the activation of the prohormone renin and high activity of angiotensin (Ang) II. Ang II is involved not only in the regulation of blood pressure, but also performs hematopoietic functions, mainly erythropoiesis and myelopoiesis. Several studies have shown the association of AGTR1 (1166A>C) angiotensin II type 1 receptor polymorphism with hypertension, vasoconstriction, and sodium retention in the body. Therefore, it is potentially important to evaluate the role of oligonucleotide polymorphism (SNP) A1166C of the AGTR1 gene in the clinical manifestation of AS, as well as its significance in the development of comorbid pathology and the formation of CVR, including hypertension. Aim : to evaluate the effect of the A1166C polymorphism of the AGTR1 gene on the development of comorbid pathology and the formation of CFS, including AH. Materials and methods : The study included 176 patients diagnosed with AS. Genotyping was carried out according to the A1166C polymorphism of the AGTR1 gene by the polymerase chain reaction method (PCR). The statistical analysis was carried out using the Kruskal-Wallis criterion. Results: Patients with the AA genotype had a higher BASMI (Bath Ankylosing Spondylitis Metrology Index) (p=0024, p1,3=0.023). CC homozygotes had lower levels of red blood cells (p=0.025, p2,3=0.02) and hemoglobin (p=0.031, p2,3=0.042), while AA genotypes had lower platelet counts (p=0.0001, p1,3=0.001). Higher glucose levels were recorded in CC homozygotes (p=0,0001, p1,3=0,001, p1,2=0,025), triglycerides — in heterozygotes AC (p=0.038). The highest incidence of enthesitis was recorded for patients with the CC genotype (p2,3=0.006, p=0.015). High incidence of hypertension (p1,2=0.05, p=0.025), dyslipidemia (p1,2=0.012, p2,3=0.006, p=0.031) was found in heterozygotes of AC. Diabetes mellitus was detected only among patients with the CC genotype(p1,3=0.007, p=0.017). Kidney damage was more often detected in carriers of the A allele (p1,3=0.015, p2,3=0.004, p=0.023). Statistical differences were found in the frequency of detection of individual degrees of hypertension (p=0.0001): in heterozygotes of AC — 2 (AA 26 (27.1 %); AC 4 (33.3 %); CC 14 (24.1 %)) and grade 3 (AA 0 (0.0 %) versus AC 2 (16.7 %) CC 0 (0.0 %), p1,2C of the AGTR1 gene, extending beyond participation in the formation of hypertension, and include the regulation of hematopoiesis, metabolic parameters, glucose and lipids in particular, and the formation of comorbid pathology in the form of diabetes mellitus, dyslipidemia, kidney pathology in patients with AS, which determines the potential and feasibility of genotyping patients with AS with the identification of SNPs in order to personalize approaches to pharmacotherapy of AS and monitoring these indicators in the presence of a risk of developing conditions associated with this SNP.
- 20 June 2026
- Published by SPb RAACI in Medical Immunology (Russia)
- Vol. 28 (2) , 275-288
The role of single nucleotide polymorphisms of VEGF gene in the development of cardiovascular diseases
Cardiovascular diseases (CVD) are the main cause of mortality in general population. Pathophysiology underlying CVD development includes inflammation, endothelial dysfunction, oxidative stress, atherosclerosis, fibrosis, dyslipidemia and thromboembolism. Endothelial dysfunction affects the balance of endothelium-dependent vasoconstriction and vasodilation by increasing cytokine levels, adhesion molecule expression, leukocyte and monocyte migration, and platelet activation. The vascular endothelial growth factor (VEGF) family is an important component of angiogenesis involved in inducing migration and proliferation of endothelial cells by modulating vascular permeability and blood clotting. The VEGF family includes 5 proteins, of which VEGF-A, VEGF-B and PlGF (placental growth factor) regulate angiogenesis, and VEGF-C and VEGF-D (c-Fos-induced growth factor, FIGF) regulate lymphangiogenesis. VEGF-A is a key factor in the angiogenesis and collateral circulation (arteriogenesis) mediated by the binding of VEGF-A to the VEGFR-1 (Flt-1) and VEGFR-2 (KDR) receptors. As a result of our search, an increased risk of coronary heart disease is expected in the case of detection of certain single oligonucleotide polymorphisms (SNPs) in VEGF-A gene, in particular: rs3025039, rs699947, rs2010963, rs1570360 and rs7667298. VEGF-D is a secreted factor that regulates lymphangiogenesis, angiogenesis, and endothelial proliferation through interaction with VEGFR2 (KDR). Some studies have demonstrated an increase in VEGF-D levels caused by rs192812042 and rs234500 polymorphisms in patients with acute and chronic coronary syndromes, thus suggesting the role of VEGF-D in the formation of CVD by involving lymphangiogenesis, as well as modulating angiogenesis. Genotyping of patients at CVD risk with identification of multiple VEGF SNPs will enable timely diagnostics of patients with initially increased risk of developing cardiovascular pathology and prescribe treatment and measures, prevent development of acute cardiovascular pathology and reduce mortality caused by CVD.
- 20 June 2026
- Published by SPb RAACI in Medical Immunology (Russia)
- Vol. 28 (2) , 275-288
The role of single nucleotide polymorphisms of VEGF gene in the development of cardiovascular diseases
Cardiovascular diseases (CVD) are the main cause of mortality in general population. Pathophysiology underlying CVD development includes inflammation, endothelial dysfunction, oxidative stress, atherosclerosis, fibrosis, dyslipidemia and thromboembolism. Endothelial dysfunction affects the balance of endothelium-dependent vasoconstriction and vasodilation by increasing cytokine levels, adhesion molecule expression, leukocyte and monocyte migration, and platelet activation. The vascular endothelial growth factor (VEGF) family is an important component of angiogenesis involved in inducing migration and proliferation of endothelial cells by modulating vascular permeability and blood clotting. The VEGF family includes 5 proteins, of which VEGF-A, VEGF-B and PlGF (placental growth factor) regulate angiogenesis, and VEGF-C and VEGF-D (c-Fos-induced growth factor, FIGF) regulate lymphangiogenesis. VEGF-A is a key factor in the angiogenesis and collateral circulation (arteriogenesis) mediated by the binding of VEGF-A to the VEGFR-1 (Flt-1) and VEGFR-2 (KDR) receptors. As a result of our search, an increased risk of coronary heart disease is expected in the case of detection of certain single oligonucleotide polymorphisms (SNPs) in VEGF-A gene, in particular: rs3025039, rs699947, rs2010963, rs1570360 and rs7667298. VEGF-D is a secreted factor that regulates lymphangiogenesis, angiogenesis, and endothelial proliferation through interaction with VEGFR2 (KDR). Some studies have demonstrated an increase in VEGF-D levels caused by rs192812042 and rs234500 polymorphisms in patients with acute and chronic coronary syndromes, thus suggesting the role of VEGF-D in the formation of CVD by involving lymphangiogenesis, as well as modulating angiogenesis. Genotyping of patients at CVD risk with identification of multiple VEGF SNPs will enable timely diagnostics of patients with initially increased risk of developing cardiovascular pathology and prescribe treatment and measures, prevent development of acute cardiovascular pathology and reduce mortality caused by CVD.
- 20 June 2026
- Published by SPb RAACI in Medical Immunology (Russia)
- Vol. 28 (2) , 359-366
Effect of T330G variant of IL2 gene on some biomarkers in patients with type 1 diabetes mellitus
Type 1 diabetes mellitus (T1DM) is an autoimmune disease characterized by a high risk of vascular complications causing disability and mortality. Immune system dysfunction, especially, imbalance of regulatory T cells (Tregs), plays a central role in pathogenesis of T1DM. Interleukin-2 (IL-2) is a key cytokine for maintaining the Treg function. The T330G (rs2069762) polymorphism in promoter region of IL2 gene may affect its production, but its association with pathological biomarkers of diabetes is not well understood. Our aim was to investigate the possible association between T330G polymorphism of IL2 gene and the levels of laboratory markers reflecting systemic inflammation, endothelial dysfunction, fibrogenesis, and intestinal barrier permeability in T1DM patients. This cross-sectional study included 90 patients with T1DM. Genotyping for the IL-2 T330G polymorphism was performed using PCR method. Plasma concentrations of angiotensin-2, transforming growth factor-b (TGF-b), endothelin-1, C-reactive protein (CRP), markers of intestinal permeability (zonulin, LBP, BPI, sCD14), and other protein factors were determined by ELISA technique. Statistical analysis was performed using non-parametric methods. It was found that the carriers of TT genotype associated with lower IL-2 production, had statistically significantly higher levels of angiotensin-2 compared to the subjects with GG genotype (median 192.4 pg/mL vs. 88.0 pg/mL; p = 0.021). Patients with the TT genotype also showed higher concentrations of TGF-b compared to the heterozygous TG group (median 2.7 ng/mL vs. 1.8 ng/mL; p = 0.015). No significant associations of T330G polymorphism were found with levels of CRP, markers of intestinal permeability, or clinical parameters, including HbA1c and the frequency of The T330G polymorphism of IL2 gene in patients with T1DM is associated with activity of renin-angiotensin system and the levels of TGF-b, the main profibrotic cytokine. The genetically determined decrease in IL-2 production (TT variant of T330G polymorphism) may contribute to hyperactivation of these systems, thus playing a key role in development of vascular complications. This gene variant could be considered a potential genetic marker for risk stratification and personalized therapy in T1DM.
- 20 June 2026
- Published by SPb RAACI in Medical Immunology (Russia)
- Vol. 28 (2) , 359-366
Effect of T330G variant of IL2 gene on some biomarkers in patients with type 1 diabetes mellitus
Type 1 diabetes mellitus (T1DM) is an autoimmune disease characterized by a high risk of vascular complications causing disability and mortality. Immune system dysfunction, especially, imbalance of regulatory T cells (Tregs), plays a central role in pathogenesis of T1DM. Interleukin-2 (IL-2) is a key cytokine for maintaining the Treg function. The T330G (rs2069762) polymorphism in promoter region of IL2 gene may affect its production, but its association with pathological biomarkers of diabetes is not well understood. Our aim was to investigate the possible association between T330G polymorphism of IL2 gene and the levels of laboratory markers reflecting systemic inflammation, endothelial dysfunction, fibrogenesis, and intestinal barrier permeability in T1DM patients. This cross-sectional study included 90 patients with T1DM. Genotyping for the IL-2 T330G polymorphism was performed using PCR method. Plasma concentrations of angiotensin-2, transforming growth factor-b (TGF-b), endothelin-1, C-reactive protein (CRP), markers of intestinal permeability (zonulin, LBP, BPI, sCD14), and other protein factors were determined by ELISA technique. Statistical analysis was performed using non-parametric methods. It was found that the carriers of TT genotype associated with lower IL-2 production, had statistically significantly higher levels of angiotensin-2 compared to the subjects with GG genotype (median 192.4 pg/mL vs. 88.0 pg/mL; p = 0.021). Patients with the TT genotype also showed higher concentrations of TGF-b compared to the heterozygous TG group (median 2.7 ng/mL vs. 1.8 ng/mL; p = 0.015). No significant associations of T330G polymorphism were found with levels of CRP, markers of intestinal permeability, or clinical parameters, including HbA1c and the frequency of The T330G polymorphism of IL2 gene in patients with T1DM is associated with activity of renin-angiotensin system and the levels of TGF-b, the main profibrotic cytokine. The genetically determined decrease in IL-2 production (TT variant of T330G polymorphism) may contribute to hyperactivation of these systems, thus playing a key role in development of vascular complications. This gene variant could be considered a potential genetic marker for risk stratification and personalized therapy in T1DM.
- 8 June 2026
- Published by Sole Proprietor Company Klyueva M.M. in International Journal of Medicine and Psychology
- Vol. 9 (4)
Показатель эрозий суставных поверхностей по сравнению с показателем сужения суставных щелей по модифицированному методу Sharp-van der Heijde сильнее ассоциирован с титром антител
введение: структурное повреждение суставов при ревматоидном артрите (РА) определяется сложным взаимодействием воспалительных и аутоиммунных механизмов. Роль гуморальных маркеров в прогрессировании рентгенологических изменений остаётся неоднозначной. Материалы и методы. Обследованы 74 пациента с РА (2023-2024 гг.). Определение РФ, АЦЦП и γ-глобулинов проводили методом ИФА. Рентгенологическую оценку выполняли с использованием шкалы Sharp-van der Heijde. Применялись корреляционный анализ Спирмена и множественный линейный регрессионный анализ (IBM SPSS 26.0). Результаты. РФ продемонстрировал сильные корреляции с эрозиями (ρ до 0,846; p<0,01) и суммарным рентгенологическим баллом (ρ=0,696; p<0,01). АЦЦП имели слабые связи (ρ до 0,326; p<0,01), γ-глобулины – умеренные (ρ≈0,33; p<0,01). РФ являлся независимым предиктором эрозий (β=0,568; p<0,001; R²=0,301) и сужения суставной щели (β=0,486; p<0,001; R²=0,234). Выводы. Ревматоидный фактор является ключевым гуморальным предиктором структурного повреждения суставов при РА и может рассматриваться как значимый маркер тяжести и прогрессирования заболевания. introduction: structural joint damage in Rheumatoid Arthritis (RA) results from a complex interplay between inflammatory and autoimmune mechanisms. The role of humoral markers in the progression of radiographic changes remains controversial. Materials and Methods. A total of 74 patients with RA (2023-2024) were examined. Levels of rheumatoid factor (RF), anti-cyclic citrullinated peptide antibodies (anti-CCP), and γ-globulins were measured using enzyme-linked immunosorbent assay (ELISA). Radiographic assessment was performed using the Sharp-van der Heijde score. Spearman correlation analysis and multiple linear regression analysis (IBM SPSS 26.0) were applied. Results. RF demonstrated strong correlations with bone erosions (ρ up to 0.846; p<0.01) and total radiographic score (ρ=0.696; p<0.01). Anti-CCP antibodies showed weak associations (ρ up to 0.326; p<0.01), while γ-globulins exhibited moderate correlations (ρ≈0.33; p<0.01). RF was an independent predictor of erosions (β=0.568; p<0.001; R²=0.301) and joint space narrowing (β=0.486; p<0.001; R²=0.234). Conclusions. Rheumatoid factor is a key humoral predictor of structural joint damage in rheumatoid arthritis and may serve as a significant marker of disease severity and progression.
- 8 June 2026
- Published by Sole Proprietor Company Klyueva M.M. in International Journal of Medicine and Psychology
- Vol. 9 (4)
Показатель эрозий суставных поверхностей по сравнению с показателем сужения суставных щелей по модифицированному методу Sharp-van der Heijde сильнее ассоциирован с титром антител
введение: структурное повреждение суставов при ревматоидном артрите (РА) определяется сложным взаимодействием воспалительных и аутоиммунных механизмов. Роль гуморальных маркеров в прогрессировании рентгенологических изменений остаётся неоднозначной. Материалы и методы. Обследованы 74 пациента с РА (2023-2024 гг.). Определение РФ, АЦЦП и γ-глобулинов проводили методом ИФА. Рентгенологическую оценку выполняли с использованием шкалы Sharp-van der Heijde. Применялись корреляционный анализ Спирмена и множественный линейный регрессионный анализ (IBM SPSS 26.0). Результаты. РФ продемонстрировал сильные корреляции с эрозиями (ρ до 0,846; p<0,01) и суммарным рентгенологическим баллом (ρ=0,696; p<0,01). АЦЦП имели слабые связи (ρ до 0,326; p<0,01), γ-глобулины – умеренные (ρ≈0,33; p<0,01). РФ являлся независимым предиктором эрозий (β=0,568; p<0,001; R²=0,301) и сужения суставной щели (β=0,486; p<0,001; R²=0,234). Выводы. Ревматоидный фактор является ключевым гуморальным предиктором структурного повреждения суставов при РА и может рассматриваться как значимый маркер тяжести и прогрессирования заболевания. introduction: structural joint damage in Rheumatoid Arthritis (RA) results from a complex interplay between inflammatory and autoimmune mechanisms. The role of humoral markers in the progression of radiographic changes remains controversial. Materials and Methods. A total of 74 patients with RA (2023-2024) were examined. Levels of rheumatoid factor (RF), anti-cyclic citrullinated peptide antibodies (anti-CCP), and γ-globulins were measured using enzyme-linked immunosorbent assay (ELISA). Radiographic assessment was performed using the Sharp-van der Heijde score. Spearman correlation analysis and multiple linear regression analysis (IBM SPSS 26.0) were applied. Results. RF demonstrated strong correlations with bone erosions (ρ up to 0.846; p<0.01) and total radiographic score (ρ=0.696; p<0.01). Anti-CCP antibodies showed weak associations (ρ up to 0.326; p<0.01), while γ-globulins exhibited moderate correlations (ρ≈0.33; p<0.01). RF was an independent predictor of erosions (β=0.568; p<0.001; R²=0.301) and joint space narrowing (β=0.486; p<0.001; R²=0.234). Conclusions. Rheumatoid factor is a key humoral predictor of structural joint damage in rheumatoid arthritis and may serve as a significant marker of disease severity and progression.
- Open Access
- 30 May 2026
- Published by Publishing House OKI in Kachestvennaya Klinicheskaya Praktika = Good Clinical Practice
- No. 2,p. 140-148
LPS-binding systems and endothelial nitric oxide synthase in gout patients
Relevance . Gout is a common inflammatory arthropathy characterized by hyperuricemia, oxidative stress, and endothelial dysfunction. Objective : To study the relationship between endotoxin-binding systems and the concentration of endothelial NO synthase (NOS3) in patients with gout. Materials and methods . The study included 41 patients with a confirmed diagnosis of gout according to the EULAR/ACR classification criteria and 33 healthy people forming the control group. Plasma concentrations were measured: highly sensitive C-reactive protein (hsCRP) NOS3 (eNOS), BPI by solid-phase ELISA. Linear regression was used to assess the relationship between BPI and NOS3 levels and the Pearson correlation coefficient (r), coefficient of determination (R2), and signifi cance level (p) were calculated. IBM SPSS Statistics 26.0 soft ware was used. Results . Patients with gout showed elevated levels of lipopolysaccharide-binding protein (LBP) and highly sensitive C-reactive protein, as well as significantly reduced BPI concentrations compared with the control group (p Conclusion . The data obtained indicate a close relationship between innate immune systems and endothelial function in gout. BPI may have a protective effect that supports endothelial function in conditions of chronic inflammation and oxidative stress. In the future, it is possible to develop a comprehensive biomarker panel BPI+NOS3 for monitoring or predicting vascular complications and individualizing therapy for gout.
- 30 May 2026
- Published by Publishing House OKI in Kachestvennaya Klinicheskaya Praktika = Good Clinical Practice
- No. 2,p. 140-148
Open AccessLPS-binding systems and endothelial nitric oxide synthase in gout patients
Relevance . Gout is a common inflammatory arthropathy characterized by hyperuricemia, oxidative stress, and endothelial dysfunction. Objective : To study the relationship between endotoxin-binding systems and the concentration of endothelial NO synthase (NOS3) in patients with gout. Materials and methods . The study included 41 patients with a confirmed diagnosis of gout according to the EULAR/ACR classification criteria and 33 healthy people forming the control group. Plasma concentrations were measured: highly sensitive C-reactive protein (hsCRP) NOS3 (eNOS), BPI by solid-phase ELISA. Linear regression was used to assess the relationship between BPI and NOS3 levels and the Pearson correlation coefficient (r), coefficient of determination (R2), and signifi cance level (p) were calculated. IBM SPSS Statistics 26.0 soft ware was used. Results . Patients with gout showed elevated levels of lipopolysaccharide-binding protein (LBP) and highly sensitive C-reactive protein, as well as significantly reduced BPI concentrations compared with the control group (p Conclusion . The data obtained indicate a close relationship between innate immune systems and endothelial function in gout. BPI may have a protective effect that supports endothelial function in conditions of chronic inflammation and oxidative stress. In the future, it is possible to develop a comprehensive biomarker panel BPI+NOS3 for monitoring or predicting vascular complications and individualizing therapy for gout.
- 30 March 2026
- Published by Far Eastern Scientific Center Of Physiology and Pathology of Respiration in Bulletin physiology and pathology of respiration
- No. 99
Clinical significance of endothelin-1 and angiotensin-2 levels in patients with post-COVID syndrome according to the timing of rehabilitation therapy
Introduction. Post-COVID syndrome (PCS) leads to multiorgan dysfunction, the primary pathophysiological basis of which is considered to be endothelial dysfunction – a state of imbalance among vasoactive and angiogenic mediators. Aim. To evaluate the clinical relevance of endothelin-1 (EDN1) and angiotensin-2 (ANG-2) levels in PCS patients in relation to the timing of enrollment in rehabilitation treatment. Materials and methods. The study included 190 patients diagnosed with PCS and 30 healthy controls with no prior history of COVID-19. Assessments encompassed clinical, functional, and laboratory evaluations, including enzyme-linked immunosorbent assay (ELISA) for serum levels of ANG-2, EDN1, bactericidal/permeability-increasing protein (BPI), and C-reactive protein (CRP). Pulmonary function was assessed by spirometry. Physical performance was measured using the 6-minute step test (6MST), dyspnea severity via the Baseline Dyspnea Index (BDI). Fatigue was assessed using the Fatigue Assessment Scale (FAS), and health-related quality of life by the SF-36 questionnaire. Results. Patients were stratified into four groups based on PCS duration: Group I (24 months). Cardiovascular comorbidities predominated in Groups I and II, whereas bronchial asthma and chronic bronchitis were more common in Groups III and IV. Notably, 11.5 % of patients developed respiratory diseases de novo after COVID-19. ANG-2 levels were elevated across all PCS groups compared to controls. EDN1 concentrations were highest in Group I (52.3 [33.3; 62.5] pg/mL) versus controls (44.4 [39.81; 47.22] pg/mL) and showed a progressive decline with longer PCS duration: Group II – 39.4 [26.4; 50.0] pg/mL; Group III – 23.2 [16.0; 40.7] pg/mL; Group IV – 18.7 [16.5; 21.7] pg/mL. FAS and SF-36 scores revealed persistent chronic fatigue and reduced quality of life – both physical and mental – among PCS patients. Conclusion. For up to two years following acute COVID-19, patients exhibit signs of unresolved low-grade inflammation and impaired endothelial vasomotor function, which underlie persistent PCS symptoms, including chronic fatigue and diminished quality of life.
- 30 March 2026
- Published by Far Eastern Scientific Center Of Physiology and Pathology of Respiration in Bulletin physiology and pathology of respiration
- No. 99
Clinical significance of endothelin-1 and angiotensin-2 levels in patients with post-COVID syndrome according to the timing of rehabilitation therapy
Introduction. Post-COVID syndrome (PCS) leads to multiorgan dysfunction, the primary pathophysiological basis of which is considered to be endothelial dysfunction – a state of imbalance among vasoactive and angiogenic mediators. Aim. To evaluate the clinical relevance of endothelin-1 (EDN1) and angiotensin-2 (ANG-2) levels in PCS patients in relation to the timing of enrollment in rehabilitation treatment. Materials and methods. The study included 190 patients diagnosed with PCS and 30 healthy controls with no prior history of COVID-19. Assessments encompassed clinical, functional, and laboratory evaluations, including enzyme-linked immunosorbent assay (ELISA) for serum levels of ANG-2, EDN1, bactericidal/permeability-increasing protein (BPI), and C-reactive protein (CRP). Pulmonary function was assessed by spirometry. Physical performance was measured using the 6-minute step test (6MST), dyspnea severity via the Baseline Dyspnea Index (BDI). Fatigue was assessed using the Fatigue Assessment Scale (FAS), and health-related quality of life by the SF-36 questionnaire. Results. Patients were stratified into four groups based on PCS duration: Group I (24 months). Cardiovascular comorbidities predominated in Groups I and II, whereas bronchial asthma and chronic bronchitis were more common in Groups III and IV. Notably, 11.5 % of patients developed respiratory diseases de novo after COVID-19. ANG-2 levels were elevated across all PCS groups compared to controls. EDN1 concentrations were highest in Group I (52.3 [33.3; 62.5] pg/mL) versus controls (44.4 [39.81; 47.22] pg/mL) and showed a progressive decline with longer PCS duration: Group II – 39.4 [26.4; 50.0] pg/mL; Group III – 23.2 [16.0; 40.7] pg/mL; Group IV – 18.7 [16.5; 21.7] pg/mL. FAS and SF-36 scores revealed persistent chronic fatigue and reduced quality of life – both physical and mental – among PCS patients. Conclusion. For up to two years following acute COVID-19, patients exhibit signs of unresolved low-grade inflammation and impaired endothelial vasomotor function, which underlie persistent PCS symptoms, including chronic fatigue and diminished quality of life.
- 5 February 2026
- Published by Synapse, LLC in The Russian Archives of Internal Medicine
- Vol. 16 (1)
Experience Of Colchicine Administration in Refractory Still’s Disease
Still’s disease (SD) is a rare chronic autoinflammatory disease manifested by the development of high peak fever, joint involvement (arthralgias and arthritis), and the appearance of a salmon-colored maculopapular rash. The 2024 EULAR guidelines unified the diagnostic criteria for Still’s disease including fever ≥39°C (102.2°F), recurrent erythematous rash, musculoskeletal involvement, neutrophilic leukocytosis, and elevated CRP and ferritin. If S100 or interleukin (IL)18 levels can be determined, their elevated values will point in favor of SD. Also, treatment strategy have been modified with the administration of biologics of IL-1 or IL-6 inhibitors if glucocorticoids (GCs) are ineffective, and the use of methotrexate (MTX) is considered if biologic therapy cannot be initiated.This case report focuses on the situation of timely diagnosis of SD and resistance to standard therapy with GCs (including pulse therapy) and MTX. Due to insufficient availability of biologics, based on the existing experience of colchicine prescription in SD in the scientific literature, the patient’s therapy was modified with the addition of colchicine at a dose of 1 mg orally per day, after the administration of which regression of clinical manifestations and normalization of acute-phase markers were noted.This clinical experience demonstrates the feasibility of colchicine administration as an alternative to biologics to reduce disease activity if SD is refractory to GC and MTX therapy.
- 5 February 2026
- Published by Synapse, LLC in The Russian Archives of Internal Medicine
- Vol. 16 (1)
Experience Of Colchicine Administration in Refractory Still’s Disease
Still’s disease (SD) is a rare chronic autoinflammatory disease manifested by the development of high peak fever, joint involvement (arthralgias and arthritis), and the appearance of a salmon-colored maculopapular rash. The 2024 EULAR guidelines unified the diagnostic criteria for Still’s disease including fever ≥39°C (102.2°F), recurrent erythematous rash, musculoskeletal involvement, neutrophilic leukocytosis, and elevated CRP and ferritin. If S100 or interleukin (IL)18 levels can be determined, their elevated values will point in favor of SD. Also, treatment strategy have been modified with the administration of biologics of IL-1 or IL-6 inhibitors if glucocorticoids (GCs) are ineffective, and the use of methotrexate (MTX) is considered if biologic therapy cannot be initiated.This case report focuses on the situation of timely diagnosis of SD and resistance to standard therapy with GCs (including pulse therapy) and MTX. Due to insufficient availability of biologics, based on the existing experience of colchicine prescription in SD in the scientific literature, the patient’s therapy was modified with the addition of colchicine at a dose of 1 mg orally per day, after the administration of which regression of clinical manifestations and normalization of acute-phase markers were noted.This clinical experience demonstrates the feasibility of colchicine administration as an alternative to biologics to reduce disease activity if SD is refractory to GC and MTX therapy.
- 1 January 2026
- Published by FSBEI HE NSMU MOH Russia in JOURNAL of SIBERIAN MEDICAL SCIENCES
- Vol. 10 (3)
The role of endotoxemia in joint damage in rheumatoid arthritis
Introduction. Rheumatoid arthritis (RA) is a chronic autoimmune disease characterized by progressive structural joint damage. Despite the efficacy of glucocorticoids (GCs) in controlling inflammation, their impact on long-term radiographic outcomes remains controversial. Aim. To assess the association between long-term glucocorticosteroid (GC) therapy and the severity of structural joint damage, and to analyze the role of endotoxemia and angiogenesis as potential mediators of these changes. Materials and methods. A comparative analysis was performed in 81 RA patients receiving long-term GC therapy and 17 apparently healthy volunteers (control group). Radiographic parameters were assessed (erosions, joint space narrowing (JSN), and the Sharp-van der Heijde score). Serum levels of lipopolysaccharide (LPS), lipopolysaccharide-binding protein (LBP), bactericidal/permeability-increasing protein (BPI), soluble CD14 (sCD14), zonulin, vascular endothelial growth factor (VEGF), and other markers were measured. Also, mediation analysis was performed. Results. Patients receiving GCs for a long time demonstrated more pronounced structural damage compared to the control group: the total erosion score was 9,5 vs. 2,0 (p = 0,003), JSN – 35,0 vs. 25,0 (p = 0,005), and the Sharp-van der Heijde score – 42,0 vs. 27,0 (p = 0,003), respectively. A more than three-fold increase in LPS levels was observed (151,92 vs. 49,25 ng/ml; p < 0,001), as well as an increase in VEGF levels (122,0 vs. 118,0 pg/mL; p = 0,010), with no differences in zonulin levels. Mediation analysis revealed a significant indirect effect of GCs on JSN via the cascade GCs → LPS → VEGF → JSN (p = 0,049), while no direct effect was observed (p = 0,112). The total effect of GCs was also significant (9,651; p = 0,023). Conclusion. Long-term GC therapy is associated with increased structural joint damage and appear to exert its effects predominantly through endotoxin-angiogenic mechanisms. These findings support the need for cautious use of GCs and closer monitoring of biomarkers of inflammation and angiogenesis.
- 1 January 2026
- Published by FSBEI HE NSMU MOH Russia in JOURNAL of SIBERIAN MEDICAL SCIENCES
- Vol. 10 (3)
The role of endotoxemia in joint damage in rheumatoid arthritis
Introduction. Rheumatoid arthritis (RA) is a chronic autoimmune disease characterized by progressive structural joint damage. Despite the efficacy of glucocorticoids (GCs) in controlling inflammation, their impact on long-term radiographic outcomes remains controversial. Aim. To assess the association between long-term glucocorticosteroid (GC) therapy and the severity of structural joint damage, and to analyze the role of endotoxemia and angiogenesis as potential mediators of these changes. Materials and methods. A comparative analysis was performed in 81 RA patients receiving long-term GC therapy and 17 apparently healthy volunteers (control group). Radiographic parameters were assessed (erosions, joint space narrowing (JSN), and the Sharp-van der Heijde score). Serum levels of lipopolysaccharide (LPS), lipopolysaccharide-binding protein (LBP), bactericidal/permeability-increasing protein (BPI), soluble CD14 (sCD14), zonulin, vascular endothelial growth factor (VEGF), and other markers were measured. Also, mediation analysis was performed. Results. Patients receiving GCs for a long time demonstrated more pronounced structural damage compared to the control group: the total erosion score was 9,5 vs. 2,0 (p = 0,003), JSN – 35,0 vs. 25,0 (p = 0,005), and the Sharp-van der Heijde score – 42,0 vs. 27,0 (p = 0,003), respectively. A more than three-fold increase in LPS levels was observed (151,92 vs. 49,25 ng/ml; p < 0,001), as well as an increase in VEGF levels (122,0 vs. 118,0 pg/mL; p = 0,010), with no differences in zonulin levels. Mediation analysis revealed a significant indirect effect of GCs on JSN via the cascade GCs → LPS → VEGF → JSN (p = 0,049), while no direct effect was observed (p = 0,112). The total effect of GCs was also significant (9,651; p = 0,023). Conclusion. Long-term GC therapy is associated with increased structural joint damage and appear to exert its effects predominantly through endotoxin-angiogenic mechanisms. These findings support the need for cautious use of GCs and closer monitoring of biomarkers of inflammation and angiogenesis.
- 30 December 2025
- Published by Practical Medicine Publishing House in Problems of Balneology, Physiotherapy and Exercise Therapy
- Vol. 102 (6) , 26-31
Experience of using mineral waters in patients with type 1 diabetes mellitus for the correction of endotoxinemia
Background. In recent years, special attention has been paid to the role of endotoxemia in the pathogenesis of chronic inflammatory processes and vascular complications of type 1 diabetes mellitus (DM1) — increased levels of circulating bacterial lipopolysaccharide (LPS). Endotoxemia occurs due to increased permeability of the intestinal barrier (“leaky gut syndrome”) and/or decreased activity of its elimination systems. Correction of endotoxemia is a promising direction in the complex therapy of DM1. Traditional approaches include strict glycemic control and the use of certain pharmacological agents, however, the search for effective non-pharmacological methods, such as the use of natural mineral waters, remains relevant. Despite the theoretical background, data on the effect of a course of mineral water intake on markers of endotoxemia and systemic inflammation in patients with DM1 are extremely limited. Aims: to evaluate the effect of mineral waters on the state of LPS-binding systems, the level of circulating lipopolysaccharide and markers of inflammation in patients with type 1 diabetes mellitus. Material and methods. The study included 53 patients with a verified diagnosis of type 1 diabetes mellitus. The intervention group (n=25), in addition to standard DM1 therapy, received non-carbonated therapeutic table mineral water “Krymskaya mineralnaya” produced by JSC “Beer and Alcohol Plant “Crimea” for 150—200 ml 3 r/d. The second group was a control group, and consisted of 28 patients who were comparable in gender and age to the experimental group. ELISA kits were used to determine the level of C-reactive protein (CRP), interleukin-6 (IL-6), zonulin, lipopolysaccharide (LPS), lipopolysaccharide-binding protein (LBP), and low-density lipoproteins (LDL), including apolipoprotein B-100 (apoB-100) manufactured by Cloud Clone Corp. (Wuhan, Hubei, China). Results. In patients of group 1, after the use of mineral waters, a significant decrease in circulating LPS (p=0.029) and apoB-100 (p=0.002) was detected, as well as a statistically significant increase in LBP (p=0.009). There were no significant changes in the studied indicators in the control group. Conclusions. The study demonstrates that a 30-day course of taking “Krymskaya” mineral water in addition to standard insulin therapy in patients with type 1 diabetes mellitus leads to a statistically significant decrease in the level of circulating lipopolysaccharide (LPS), a key trigger of endotoxemia and chronic inflammation. The results obtained justify the expediency of further studying the use of mineral waters, in particular bicarbonate-chloride-sodium, as a component of complex non-pharmacological therapy aimed at correcting endotoxemia and improving the metabolic profile in patients with type 1 diabetes mellitus.
- 30 December 2025
- Published by Practical Medicine Publishing House in Problems of Balneology, Physiotherapy and Exercise Therapy
- Vol. 102 (6) , 26-31
Experience of using mineral waters in patients with type 1 diabetes mellitus for the correction of endotoxinemia
Background. In recent years, special attention has been paid to the role of endotoxemia in the pathogenesis of chronic inflammatory processes and vascular complications of type 1 diabetes mellitus (DM1) — increased levels of circulating bacterial lipopolysaccharide (LPS). Endotoxemia occurs due to increased permeability of the intestinal barrier (“leaky gut syndrome”) and/or decreased activity of its elimination systems. Correction of endotoxemia is a promising direction in the complex therapy of DM1. Traditional approaches include strict glycemic control and the use of certain pharmacological agents, however, the search for effective non-pharmacological methods, such as the use of natural mineral waters, remains relevant. Despite the theoretical background, data on the effect of a course of mineral water intake on markers of endotoxemia and systemic inflammation in patients with DM1 are extremely limited. Aims: to evaluate the effect of mineral waters on the state of LPS-binding systems, the level of circulating lipopolysaccharide and markers of inflammation in patients with type 1 diabetes mellitus. Material and methods. The study included 53 patients with a verified diagnosis of type 1 diabetes mellitus. The intervention group (n=25), in addition to standard DM1 therapy, received non-carbonated therapeutic table mineral water “Krymskaya mineralnaya” produced by JSC “Beer and Alcohol Plant “Crimea” for 150—200 ml 3 r/d. The second group was a control group, and consisted of 28 patients who were comparable in gender and age to the experimental group. ELISA kits were used to determine the level of C-reactive protein (CRP), interleukin-6 (IL-6), zonulin, lipopolysaccharide (LPS), lipopolysaccharide-binding protein (LBP), and low-density lipoproteins (LDL), including apolipoprotein B-100 (apoB-100) manufactured by Cloud Clone Corp. (Wuhan, Hubei, China). Results. In patients of group 1, after the use of mineral waters, a significant decrease in circulating LPS (p=0.029) and apoB-100 (p=0.002) was detected, as well as a statistically significant increase in LBP (p=0.009). There were no significant changes in the studied indicators in the control group. Conclusions. The study demonstrates that a 30-day course of taking “Krymskaya” mineral water in addition to standard insulin therapy in patients with type 1 diabetes mellitus leads to a statistically significant decrease in the level of circulating lipopolysaccharide (LPS), a key trigger of endotoxemia and chronic inflammation. The results obtained justify the expediency of further studying the use of mineral waters, in particular bicarbonate-chloride-sodium, as a component of complex non-pharmacological therapy aimed at correcting endotoxemia and improving the metabolic profile in patients with type 1 diabetes mellitus.